Loading company…
Sinotau Pharmaceutical is a Chinese biopharmaceutical company focused on targeted radiopharmaceutical therapy and precision diagnostics.
Sinotau Pharmaceutical Group develops targeted therapy and precision diagnostic radiopharmaceuticals, along with antibody biologics for tumors, neurodegenerative diseases and autoimmune diseases. It runs molecular imaging bases in Jiangsu, Guangdong and Sichuan and works with more than 300 hospitals. Established in 2005 in Beijing, China, the company raised over CNY 1.1 billion in Series E funding in July 2023 from Beijing GAGE Capital Management Company Ltd. and CCT Fund Management, among others.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in